- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
>
>
> High Prevalence of Vitamin D Deficiency Among Chronic Hepatitis B Patients Entering a Large Global Prospective Trial (Study GS-US-174-0149) - see attached full poster report
>
>
>
> Reported by Jules Levin
>
> Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6–10, 2013, Singapore
>
>
>
> Magdy Elkashab1, Graham R. Foster2, Yoon Jun Kim3, Prista Charuworn4, Eduardo B. Martins4, Ben Mitchell4, Phillip Dinh4, Won Young Tak5, Henry Chan6, Xiaoli Ma7, Huy Trinh8
>
> 1The Toronto Liver Centre, Toronto, Ontario, Canada; 2Queen Mary University of London, London, UK; 3Seoul National University Hospital, Seoul, South Korea; 4Gilead Sciences, Inc., Foster City, CA, USA; 5Kyungpook National University Hospital, Daegu, South Korea; 6Prince of Wales Hospital, Shatin, New Territories, Hong Kong; 7Drexel University, Philadelphia, PA, USA; 8San Jose Gastroenterology, San Jose, CA, USA
>
> CONCLUSIONS
>
> Low pretreatment vitamin D levels were highly prevalent in these patients with chronic HBV infection, affecting 93.2% of the enrolled study population
> – More than half the patients had vitamin D levels that could be classified as vitamin D deficiency (<20 ng/mL)
>
> Multivariate analysis suggested a significant association of vitamin D level with season of blood draw, HBV DNA GT, race (white vs not white), calcium level, log10 HBV DNA, HBeAg status, and age at baseline
>
> Future directions will focus on impact of pretreatment vitamin D level on the response to various therapies, including combination PEG and TDF treatment, in patients with chronic HBV infection
>
>
>
>维生素D缺乏症的患病率较高,其中慢性乙型肝炎患者进入全球大型前瞻性研究(研究GS-US-174-0149) - 见附表海报报告
>
>
>
>记者朱莱
>
亚太肝脏研究学会(APASL)肝周,6月6-10日,2013年,新加坡
>
>
>
麦格迪Elkashab1,格雷厄姆·Foster2,尹君Kim3,普里斯塔Charuworn4,爱德华B. Martins4,本菲利普Dinh4 Mitchell4,赢得年轻Tak5,亨利,小丽MA7,休伊Trinh8 Chan6
>
>1The多伦多肝脏中心,加拿大安大略省,多伦多,伦敦大学玛丽2Queen学院,伦敦,英国,韩国首尔国立大学医院,3Seoul;4Gilead科学公司,福斯特城,CA,USA;5Kyungpook国立大学医院,大邱,韩国,香港新界沙田威尔斯亲王医院,7Drexel大学,费城,宾夕法尼亚州,美国;8San何塞消化,圣何塞,加利福尼亚州,美国6Prince
>
>结论
>
>低预处理维生素D水平非常普遍,在这些患者中,慢性HBV感染,影响登记研究人口的93.2%
> - 超过一半的患者有维生素D的水平,可以被归类为维生素D缺乏(<20毫微克/毫升)
>
>多因素分析显示维生素D水平与抽血GT,种族,HBV DNA(白与不白),钙水平,log10的HBV DNA,HBeAg状态的季节,一个显着的关联和基线时的年龄
>
>未来的发展方向,将重点放在应对各种疗法,包括组合PEG和TDF治疗,在慢性HBV感染患者的预处理维生素D水平的影响
|
|